1. Home
  2. CYTK vs APLD Comparison

CYTK vs APLD Comparison

Compare CYTK & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • APLD
  • Stock Information
  • Founded
  • CYTK 1997
  • APLD 2001
  • Country
  • CYTK United States
  • APLD United States
  • Employees
  • CYTK N/A
  • APLD N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • APLD Investment Bankers/Brokers/Service
  • Sector
  • CYTK Health Care
  • APLD Finance
  • Exchange
  • CYTK Nasdaq
  • APLD Nasdaq
  • Market Cap
  • CYTK 4.6B
  • APLD 3.7B
  • IPO Year
  • CYTK 2004
  • APLD N/A
  • Fundamental
  • Price
  • CYTK $49.76
  • APLD $19.46
  • Analyst Decision
  • CYTK Buy
  • APLD Strong Buy
  • Analyst Count
  • CYTK 15
  • APLD 12
  • Target Price
  • CYTK $75.57
  • APLD $14.25
  • AVG Volume (30 Days)
  • CYTK 2.7M
  • APLD 26.3M
  • Earning Date
  • CYTK 11-05-2025
  • APLD 10-08-2025
  • Dividend Yield
  • CYTK N/A
  • APLD N/A
  • EPS Growth
  • CYTK N/A
  • APLD N/A
  • EPS
  • CYTK N/A
  • APLD N/A
  • Revenue
  • CYTK $85,738,000.00
  • APLD $144,193,000.00
  • Revenue This Year
  • CYTK $330.96
  • APLD $87.62
  • Revenue Next Year
  • CYTK $73.41
  • APLD $81.14
  • P/E Ratio
  • CYTK N/A
  • APLD N/A
  • Revenue Growth
  • CYTK 2635.74
  • APLD 5.54
  • 52 Week Low
  • CYTK $29.31
  • APLD $3.31
  • 52 Week High
  • CYTK $59.39
  • APLD $19.96
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 63.01
  • APLD 73.42
  • Support Level
  • CYTK $49.22
  • APLD $13.16
  • Resistance Level
  • CYTK $53.58
  • APLD $19.96
  • Average True Range (ATR)
  • CYTK 2.54
  • APLD 1.18
  • MACD
  • CYTK 0.29
  • APLD 0.33
  • Stochastic Oscillator
  • CYTK 76.53
  • APLD 92.65

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About APLD Applied Digital Corporation

Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.

Share on Social Networks: